Common Contracts

Contract

January 17th, 2020

• Filed
  January 17th, 2020

AMENDMENT # 1 TO CLINICAL TRIAL AGREEMENT DODATOK Č. 1 K ZMLUVE O 501/20KLINICKOM SKÚŠANÍ Protocol # KHB-1802 Protokol č. KHB-1802 This Amendment # 1 (“Amendment”), effective as of the date following its publication in the central register of contracts (“Effective Date”)between Tento dodatok č. 1 (ďalej len „dodatok“), účinný dňom nasledujúcim po dni jeho zverejnenia v centrálnom registri zmlúv medzi spoločnosťou Syneos Health UK Limited, with principal offices located at Farnborough Business Park, 1 Pinehurst Road, Farnborough, Hampshire, GU14 7BF, United Kingdom, including its affiliates andsubsidiaries (“CRO”) Syneos Health UK Limited, s hlavným sídlom podnikania na adrese Farnborough Business Park,1 Pinehurst Road, Farnborough, Hampshire, GU14 7BF, Velká Británia, vrátane jej pobočieka dcérskych spoločností (ďalej len „CRO“) and a CHENGDU KANGHONG BIOTECHNOLOGY CO., LTD., with aprincipal place of business at 108 Shuxi Road, Jinniu Dis, Chengdu 610036, China (“Sp